Clinical trial
Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)
NCT00196105 · Cook Group Incorporated, Industry · Completed
Key facts
| NCT number | NCT00196105 |
|---|---|
| Title | Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) |
| Official title | Multicenter Prospective Randomized Controlled Trial of the Nitinol ZILVER Expandable Endoprosthesis in the Palliation of Extrahepatic Malignant Biliary Obstruction |
| Lead sponsor | Cook Group Incorporated, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Biliary Tract Neoplasms, Pancreatic Neoplasms, Jaundice, Obstructive |
| Intervention type | Device |
| Interventions | 6 mm Nitinol Zilver Stent, 10 mm Nitinol Zilver Stent, 10 mm Stainless Steel Wallstent |
| Enrollment | 241 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: